Abstract
The design of formulations intended for inhalation is a major challenge since many different factors need consideration in order to guarantee major drug delivery. This becomes especially important in dry powder inhalation. Balanced inter-particle interactions between carrier and drug particles are key factors for an optimal aerodynamic performance. This work combines an experimental approach utilising spherical glass beads as model carrier and simulations of device properties as well as particle-particle interactions to gain deeper understanding of processes during inhalation and their effect on aerodynamic performance. Surface roughness modification of the carrier proved to influence the effective drug loading of distinct drug particles. Moreover, surface topography had a major impact on the aerodynamic performance as micron-sized indentations drastically reduced the fine particle fraction (FPF). This could be linked to their ability of sheltering drug particles from the airstream during inhalation. Nano-scale roughness on the other hand led to a significant increase of the FPF. The impact of the inhalation device itself was also taken into account. The conducted numerical calculations (CFD) have provided more insight into carrier particle transport and drug detachment in the case of carrier-based formulations. A multi-scale approach was adopted to numerically analyse the performance of inhaler devices. First, the motion of carrier particles through a swirl-type inhaler was simulated to provide information on flow stresses acting on carrier and on wall collision statistics. Fully resolved simulations of carrier covered by hundreds of drug particles in connection with measured adhesion properties showed that flow-induced drug detachment will only be possible if the van der Waals force between carrier and drug is very weak (i.e. requiring surface modification). However, in the considered swirl-type inhaler the wall collision number of carriers is quite high, being the reason for an efficient drug detachment through inertia. A developed wall collision detachment model revealed that almost 100% of the drug powder is detached within the inhaler, which does not correspond to experimental observations. Consequently, also drug powder deposition on the inhaler walls needs to be accounted for, in order to allow correct predictions of the emitted dose.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rau, J.L.: The inhalation of drugs: advantages and problems. Respir. Care 50, 367–382 (2005)
Pham, D.-D., Fattal, E., Tsapis, N.: Pulmonary drug delivery systems for tuberculosis treatment. Int. J. Pharm. 478, 517–529 (2015)
Onoue, S., Yamada, S.: Pirfenidone in respirable powder form for the treatment of pulmonary fibrosis: a safer alternative to the current oral delivery system? Ther. Deliv. 4, 887–889 (2013)
Thiringer, G., Svedmyr, N.: Comparison of infused and inhaled terbutaline in patients with asthma. Scand. J. Respir. Dis. 57, 17–24 (1976)
Zhou, Q.T., Leung, S.S.Y., Tang, P., Parumasivam, T., Loh, Z.H., Chan, H.-K.: Inhaled formulations and pulmonary drug delivery systems for respiratory infections. Adv. Drug Deliv. Rev. 85, 83–99 (2015)
Kwok, P.C.L., Chan, H.-K.: Pulmonary delivery of peptides and proteins. In: van der Walle, C. (ed.) Peptide and Protein Delivery, pp. 23–46. Elsevier Science, San Diego, CA, USA (2011)
Garcia-Contreras, L., Smyth, H.: Liquid-spray or dry-powder systems for inhaled delivery of peptides and proteins? Am. J. Drug Deliv. 3, 29–45 (2005)
Wall, D.A.: Pulmonary absorption of peptides and proteins. Drug Deliv. 2, 1–20 (2008)
Kwok, P.C.L., Chan, H.-K.: Pulmonary drug delivery. Ther. Deliv. 4, 877–878 (2013)
Chrystyn, H.: Is total particle dose more important than particle distribution? Respir. Med. 91, 17–19 (1997)
Ashurt, I., Malton, A., Prime, D., Sumby, B.: Latest advances in the development of dry powder inhalers. Pharm. Sci. Technol. Today 3, 246–256 (2000)
Kawashima, Y., Imai, M., Takeuchi, H., Yamamoto, H., Kamiya, K., Hino, T.: Improved flowability and compactibility of spherically agglomerated crystals of ascorbic acid for direct tableting designed by spherical crystallization process. Powder Technol. 130, 283–289 (2003)
Podczeck, F.: The relationship between physical properties of lactose monohydrate and the aerodynamic behaviour of adhered drug particles. Int. J. Pharm. 160, 119–130 (1998)
Shur, J., Saluja, B., Lee, S., Tibbatts, J., Price, R.: Effect of device design and formulation on the in vitro comparability for multi-dose dry powder inhalers. AAPS J. 17, 1105–1116 (2015)
Telko, M.J., Hickey, J.A.: Dry powder inhaler formulation. Respir. Care 50, 1209–1227 (2005)
Lohrmann, M.: Adhäsionskräfte in interaktiven Mischungen für Pulverinhalatoren (2005)
Young, P.M., Roberts, D., Chiou, H., Rae, W., Chan, H.-K., Traini, D.: Composite carriers improve the aerosolisation efficiency of drugs for respiratory delivery. J. Aerosol Sci. 39, 82–93 (2008)
Larhrib, H., Martin, G.P., Marriott, C., Prime, D.: The influence of carrier and drug morphology on drug delivery from dry powder formulations. Int. J. Pharm. 257, 283–296 (2003)
Zeng, X.M., Martin, G.P., Marriott, C., Pritchard, J.: The influence of crystallization conditions on the morphology of lactose intended for use as a carrier for dry powder aerosols. J. Pharm. Pharmacol. 52, 633–643 (2000)
Zeng, X.M., Martin, G.P., Marriott, C., Pritchard, J.: The use of lactose recrystallised from carbopol gels as a carrier for aerosolised salbutamol sulphate. Eur. J. Pharm. Biopharm. 51, 55–62 (2001)
Chan, L.W., Lim, L.T., Heng, P.W.S.: Immobilization of fine particles on lactose carrier by precision coating and its effect on the performance of dry powder formulations. J. Pharm. Sci. 92, 975–984 (2003)
Iida, K., Todo, H., Okamoto, H., Danjo, K., Leuenberger, H.: Preparation of dry powder inhalation with lactose carrier particles surface-coated using a Wurster fluidized bed. Chem. Pharm. Bull. 53, 431–434 (2005)
Adi, H., Larson, I., Stewart, P.: Use of milling and wet sieving to produce narrow particle size distributions of lactose monohydrate in the sub-sieve range. Powder Technol. 179, 95–99 (2007)
Dickhoff, B.H.J., de Boer A.H., Lambregts, D., Frijlink, H.W.: The effect of carrier surface and bulk properties on drug particle detachment from crystalline lactose carrier particles during inhalation, as function of carrier payload and mixing time. Eur. J. Pharm. Biopharm. 56, 291–302 (2003)
El-Sabawi, D., Price, R., Edge, S., Young, P.M.: Novel temperature controlled surface dissolution of excipient particles for carrier based dry powder inhaler formulations. Drug Dev. Ind. Pharm. 32, 243–251 (2006)
Iida, K., Hayakawa, Y., Okamoto, H., Danjo, K., Leuenberger, H.: Preparation of dry powder inhalation by surface treatment of lactose carrier particles. Chem. Pharm. Bull. 51, 1–5 (2003)
Islam, N., Stewart, P., Larson, I., Hartley, P.: Lactose surface modification by decantation: are drug-fine lactose ratios the key to better dispersion of salmeterol xinafoate from lactose-interactive mixtures? Pharm. Res. 21, 492–499 (2004)
Littringer, E.M., Mescher, A., Eckhard, S., Schröttner, H., Langes, C., Fries, M., et al.: Spray drying of mannitol as a drug carrier—the impact of process parameters on product properties. Dry. Technol. 30, 114–124 (2012)
Maas, S.G., Schaldach, G., Littringer, E.M., Mescher, A., Griesser, U.J., Braun, D.E., et al.: The impact of spray drying outlet temperature on the particle morphology of mannitol. Powder Technol. 213, 27–35 (2011)
Littringer, E.M., Mescher, A., Schroettner, H., Achelis, L., Walzel, P., Urbanetz, N.A.: Spray dried mannitol carrier particles with tailored surface properties—the influence of carrier surface roughness and shape. Eur. J. Pharm. Biopharm. 82, 194–204 (2012)
Ferrari, F., Cocconi, D., Bettini, R., Giordano, F., Santi, P., Tobyn, M., et al.: The surface roughness of lactose particles can be modulated by wet-smoothing using a high-shear mixer. AAPS PharmSciTech 5, 1–6 (2004)
Young, P.M., Cocconi, D., Colombo, P., Bettini, R., Price, R., Steele, D.F., et al.: Characterization of a surface modified dry powder inhalation carrier prepared by ‘‘particle smoothing’’. J. Pharm. Pharmacol. 1339–44 (2002)
Iida, K., Inagaki, Y., Todo, H., Okamoto, H., Danjo, K., Luenberger, H.: Effects of surface processing of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate. Chem. Pharm. Bull. 52, 938–942 (2004)
Steckel, H., Markefka, P., TeWierik, H., Kammelar, R.: Effect of milling and sieving on functionality of dry powder inhalation products. Int. J. Pharm. 309, 51–59 (2006)
Maas, S.G.: Optimierung trägerbasierter Pulverinhalate durch Modifikation der Trägeroberfläche mittels Sprühtrocknung (2009)
Kawashima, Y., Serigano, T., Hino, T., Yamamoto, H., Takeuchi, H.: Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate. Int. J. Pharm. 172, 179–188 (1998)
Steckel, H., Mu, B.W.: In vitro evaluation of dry powder inhalers II: influence of carrier particle size and concentration on in vitro deposition. Int. J. Pharm. 154, 31–37 (1997)
Srichana, T., Martin, G.P., Marriott, C.: Dry powder inhalers: the influence of device resistance and powder formulation on drug and lactose deposition in vitro. Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci. 7, 73–80 (1998)
Telko, M.J., Dsc, A.J.H.: Dry powder inhaler formulation. Respir. Care 50, 1209–1227 (2005)
Chew, N.Y.K., Chan, H.-K.: The role of particle properties in pharmaceutical powder inhalation formulations. J. Aerosol Med. 15, 325–330 (2002)
Newman, S.P., Busse, W.W.: Evolution of dry powder inhaler design, formulation, and performance. Respir. Med. 96, 293–304 (2002)
Wong, W., Fletcher, D.F., Traini, D., Chan, H.-K., Young, P.M.: The use of computational approaches in inhaler development. Adv. Drug Deliv. Rev. 64, 312–322 (2012)
Ruzycki, C.A., Javaheri, E., Finlay, W.H.: The use of computational fluid dynamics in inhaler design. Expert. Opin. Drug Deliv. 10, 307–323 (2013)
Sommerfeld, M., Schmalfuß, S.: Numerical analysis of carrier particle motion in a dry powder inhaler. J. Fluids Eng. 138, 041308 (2015)
Coates, M.S., Fletcher, D.F., Chan, H.-K., Raper, J.A.: Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 1: Grid structure and mouthpiece length. J. Pharm. Sci. 93, 2863–2876 (2004)
Coates, M.S., Chan, H.-K., Fletcher, D.F., Raper, J.A.: Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 2: Air inlet size. J. Pharm. Sci. 95, 1382–1392 (2006)
Coates, M.S., Chan, H.-K., Fletcher, D.F., Chiou, H.: Influence of mouthpiece geometry on the aerosol delivery performance of a dry powder inhaler. Pharm. Res. 24, 1450–1456 (2007)
Coates, M.S., Fletcher, D.F., Chan, H.-K., Raper, J.A.: The role of capsule on the performance of a dry powder inhaler using computational and experimental analyses. Pharm. Res. 22, 923–931 (2005)
Donovan, M.J., Kim, S.H., Raman, V., Smyth, H.D.: Dry powder inhaler device influence on carrier particle performance. J. Pharm. Sci. 101, 1097–1107 (2012)
Milenkovic, J., Alexopoulos, A.H., Kiparissides, C.: Flow and particle deposition in the Turbuhaler: a CFD simulation. Int. J. Pharm. 448, 205–213 (2013)
de Boer, A.H., Hagedoorn, P., Woolhouse, R., Wynn, E.: Computational fluid dynamics (CFD) assisted performance evaluation of the TwincerTM disposable high-dose dry powder inhaler. J. Pharm. Pharmacol. 64, 1316–1325 (2012)
Behara, S.R.B., Longest, P.W., Farkas, D.R., Hindle, M.: Development and comparison of new high-efficiency dry powder inhalers for carrier-free formulations. J. Pharm. Sci. 103, 465–477 (2014)
Tong, Z.B., Yang, R.Y., Chu, K.W., Yu, A.B., Adi, S., Chan, H.K.: Numerical study of the effects of particle size and polydispersity on the agglomerate dispersion in a cyclonic flow. Chem. Eng. J. 164, 432–441 (2010)
Yang, J., Wu, C.-Y., Adams, M.: Three-dimensional DEM-CFD analysis of air-flow-induced detachment of API particles from carrier particles in dry powder inhalers. Acta Pharm. Sin. B 4, 52–59 (2014)
van Wachem, B., Thalberg, K., Remmelgas, J., Niklasson-Björn, I.: Simulation of dry powder inhalers: combining micro-scale, meso-scale and macro-scale modeling. AIChE J. 63, 501–516 (2017)
Hoppentocht, M., Hagedoorn, P., Frijlink, H.W., De Boer, A.H.: Technological and practical challenges of dry powder inhalers and formulations. Adv. Drug Deliv. Rev. 75, 18–31 (2014)
Rahimpour, Y., Kouhsoltani, M., Hamishehkar, H.: Alternative carriers in dry powder inhaler formulations. Drug Discov. Today 19, 618–626 (2014)
Zellnitz, S., Redlinger-Pohn, J.D., Kappl, M., Schroettner, H., Urbanetz, N.A.: Preparation and characterization of physically modified glass beads used as model carriers in dry powder inhalers. Int. J. Pharm. 447, 132–138 (2013)
Cui, Y., Schmalfuß, S., Zellnitz, S., Sommerfeld, M., Urbanetz, N.A.: Towards the optimisation and adaptation of dry powder inhalers. Int. J. Pharm. 470, 120–132 (2014)
Cui, Y., Sommerfeld, M.: Forces on micron-sized particles randomly distributed on the surface of larger particles and possibility of detachment. Int. J. Multiph. Flow 72, 39–52 (2015)
Cui, Y., Sommerfeld, M.: Application of Lattice-Boltzmann method for analysing detachment of micron-sized particles from carrier particles in turbulent flows. Flow Turbul. Combust. 100, 271–297 (2018)
Cui, Y., Sommerfeld, M.: The modelling of carrier-wall collision with drug particle detachment for dry powder inhaler applications. Powder Technol. 344, 741–755 (2019). https://doi.org/10.1016/j-powtec.2018.12.067
Sommerfeld, M., Cui, Y., Schmalfuß, S.: Potentials and constraints for the application of CFD combined with Lagrangian particle tracking to dry powder inhalers. Eur. J. Pharm. Sci. 129, 299–324 (2019)
Milenkovic, J., Alexopoulos, A.H., Kiparissides, C.: Deposition and fine particle production during dynamic flow in a dry powder inhaler: a CFD approach. Int. J. Pharm. 461, 129–136 (2014)
Littringer, E.M., Zellnitz, S., Hammernik, K., Adamer, V., Friedl, H., Urbanetz, N.A.: Spray drying of aqueous salbutamol sulfate solutions using the Nano Spray Dryer B-90—the impact of process parameters on particle size. Dry. Technol. 31, 1346–1353 (2013)
Flament, M.-P., Leterme, P., Gayot, A.: The influence of carrier roughness on adhesion, content uniformity and the in vitro deposition of terbutaline sulphate from dry powder inhalers. Int. J. Pharm. 275, 201–209 (2004)
Renner, N., Steckel, H., Urbanetz, N., Scherließ, R.: Nano- and microstructured model carrier surfaces to alter dry powder inhaler performance. Int. J. Pharm. 518, 20–28 (2017)
Friebel, C., Steckel, H., Müller, B.W.: Rational design of a dry powder inhaler: device design and optimisation. J. Pharm. Pharmacol. 64, 1303–1315 (2012)
Friebel, C.: Rational development of an inhalation system. Ph.D. Thesis, Kiel University (2010)
Ariane, M., Sommerfeld, M., Alexiadis, A.: Wall collision and drug-carrier detachment in dry powder inhalers: using DEM to devise a sub-scale model for CFD calculations. Powder Technol. 334, 65–75 (2018)
Sommerfeld, M., van Wachem, B., Oliemans, R.: Best Practice Guidelines for Computational Fluid Dynamics of Dispersed Multiphase Flows. ERCOFTAC (European Research Community on Flow, Turbulence and Combustion). ISBN 978-91-633-3564-8 (2008)
Sommerfeld, M.: Modelling of particle-wall collisions in confined gas-particle flows. Int. J. Multiph. Flow 18, 905–926 (1992)
Sommerfeld, M., Huber, N.: Experimental analysis and modelling of particle-wall collisions. Int. J. Multiph. Flow 25, 1457–1489 (1999)
Dietzel, M., Sommerfeld, M.: Numerical calculation of flow resistance for agglomerates with different morphology by the Lattice-Boltzmann method. Powder Technol. 250, 122–137 (2013)
Ibrahim, A.H., Dunn, P.F., Brach, R.M.: Microparticle detachment from surfaces exposed to turbulent air flow: controlled experiments and modeling. J. Aerosol Sci. 34, 765–782 (2003)
Goldasteh, I., Ahmadi, G., Ferro, A.R.: Monte Carlo simulation of micron size spherical particle removal and resuspension from substrate under fluid flows. J. Aerosol Sci. 66, 62–71 (2013)
Zellnitz, S., Schroettner, H., Urbanetz, N.A.: Influence of surface characteristics of modified glass beads as model carriers in dry powder inhalers (DPIs) on the aerosolization performance. Drug Dev. Ind. Pharm. 1–8 (2015)
Crowe, C.T., Schwarzkopf, J.D., Sommerfeld, M., Tsuji, Y.: Multiphase Flows with Droplets and Particles, 2nd edn. CRC Press, Boca Raton, U.S.A (2012). ISBN 978-1-4398-4050-4
Tsuji, Y., Morikawa, Y., Tanaka, T., Nakatsukasa, N., Nakatani, M.: Numerical simulation of gas-solid two-phase flow in a two-dimensional horizontal channel. Int. J. Multiph. Flow 13, 671–684 (1987)
Renner, N.: Understanding interparticle interactions in dry powder inhalation: glass beads as an innovative model carrier system, p. 181. Dissertation, Department of Pharmaceutics and Biopharmaceutics, Kiel University (2017)
Acknowledgements
The authors acknowledge the funding of this research project by the German Research Foundation (DFG) within the priority program SPP 1486 “Particles in Contact”. The authors would also like to thank the research group of Dr. Michael Kappl and Dr. Regina Fuchs (Max Planck Institute for Polymer Research, Mainz) for providing technical support and equipment for AFM measurements. Further, the authors would thank Hartmuth Schroettner from FELMI-ZFE (Institute of Electron Microscopy and Nanoanalysis) for providing SEM images.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Zellnitz, S. et al. (2019). The Importance of Interactions Between Carrier and Drug Particles for the Application in Dry Powder Inhalers. In: Antonyuk, S. (eds) Particles in Contact. Springer, Cham. https://doi.org/10.1007/978-3-030-15899-6_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-15899-6_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-15898-9
Online ISBN: 978-3-030-15899-6
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)